InspireMD, Inc.(NYSE Amex Equities : NSPR)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Medical Specialties
|TMO||Thermo Fisher Scientific, Inc.||-0.18%||450.68||1.0%||$805.65m|
|BSX||Boston Scientific Corp.||-2.32%||38.75||1.0%||$453.86m|
|ISRG||Intuitive Surgical, Inc.||-0.67%||736.80||2.3%||$400.74m|
|ALGN||Align Technology, Inc.||1.98%||567.11||6.4%||$366.97m|
|BDX||Becton, Dickinson & Co.||-2.49%||240.99||1.0%||$355.15m|
|IDXX||IDEXX Laboratories, Inc.||0.37%||520.17||3.8%||$278.83m|
|BAX||Baxter International, Inc.||-1.35%||77.59||1.8%||$246.96m|
|INO||Inovio Pharmaceuticals, Inc.||-3.39%||11.10||4.8%||$246.95m|
|ZBH||Zimmer Biomet Holdings, Inc.||-0.86%||163.09||1.7%||$230.58m|
|EW||Edwards Lifesciences Corp.||-1.16%||83.00||0.4%||$223.88m|
InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.